Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Smith & Wesson (NASDAQ:SWBI) Misses Q1 Revenue Estimates, Stock Drops 12.4%

By: StockStory

June 18, 2025 at 16:14 PM EDT

SWBI Cover Image

American firearms manufacturer Smith & Wesson (NASDAQ: SWBI) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 11.6% year on year to $140.8 million. Its non-GAAP profit of $0.20 per share was 13% below analysts’ consensus estimates.

Is now the time to buy Smith & Wesson? Find out by accessing our full research report, it’s free.

Smith & Wesson (SWBI) Q1 CY2025 Highlights:

Revenue: $140.8 million vs analyst estimates of $152.4 million (11.6% year-on-year decline, 7.6% miss)
Adjusted EPS: $0.20 vs analyst expectations of $0.23 (13% miss)
Adjusted EBITDA: $24.14 million vs analyst estimates of $26.19 million (17.2% margin, 7.8% miss)
Operating Margin: 9.3%, down from 16% in the same quarter last year
Free Cash Flow Margin: 23.8%, similar to the same quarter last year
Market Capitalization: $461.6 million

Company Overview

With a history dating back to 1852, Smith & Wesson (NASDAQ: SWBI) is a firearms manufacturer known for its handguns and rifles.

Revenue Growth

Reviewing a company’s long-term sales performance reveals insights into its quality. Any business can put up a good quarter or two, but many enduring ones grow for years. Over the last five years, Smith & Wesson’s demand was weak and its revenue declined by 2.2% per year. This wasn’t a great result and suggests it’s a low quality business.

We at StockStory place the most emphasis on long-term growth, but within consumer discretionary, a stretched historical view may miss a company riding a successful new product or trend. Smith & Wesson’s revenue over the last two years was flat, sugggesting its demand was weak but stabilized after its initial drop. Smith & Wesson Year-On-Year Revenue Growth

This quarter, Smith & Wesson missed Wall Street’s estimates and reported a rather uninspiring 11.6% year-on-year revenue decline, generating $140.8 million of revenue.

Looking ahead, sell-side analysts expect revenue to grow 4.5% over the next 12 months. While this projection indicates its newer products and services will catalyze better top-line performance, it is still below the sector average.

Today’s young investors won’t have read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.

Operating Margin

Smith & Wesson’s operating margin has shrunk over the last 12 months and averaged 7.5% over the last two years. The company’s profitability was mediocre for a consumer discretionary business and shows it couldn’t pass its higher operating expenses onto its customers.

In Q1, Smith & Wesson generated an operating margin profit margin of 9.3%, down 6.6 percentage points year on year. This contraction shows it was less efficient because its expenses increased relative to its revenue.

Earnings Per Share

We track the long-term change in earnings per share (EPS) for the same reason as long-term revenue growth. Compared to revenue, however, EPS highlights whether a company’s growth is profitable.

Sadly for Smith & Wesson, its EPS declined by 17.7% annually over the last five years, more than its revenue. This tells us the company struggled because its fixed cost base made it difficult to adjust to shrinking demand.

Smith & Wesson Trailing 12-Month EPS (Non-GAAP)

In Q1, Smith & Wesson reported EPS at $0.20, down from $0.45 in the same quarter last year. This print missed analysts’ estimates. Over the next 12 months, Wall Street expects Smith & Wesson to perform poorly. Analysts forecast its full-year EPS of $0.31 will hit $0.45.

Key Takeaways from Smith & Wesson’s Q1 Results

We struggled to find many positives in these results as its revenue, EPS, and EBITDA fell short of Wall Street’s estimates. Overall, this quarter could have been better. The stock traded down 12.4% to $9.54 immediately following the results.

The latest quarter from Smith & Wesson’s wasn’t that good. One earnings report doesn’t define a company’s quality, though, so let’s explore whether the stock is a buy at the current price. If you’re making that decision, you should consider the bigger picture of valuation, business qualities, as well as the latest earnings. We cover that in our actionable full research report which you can read here, it’s free.

About Us

Laser Focus World Membership

Magazine Subscription

Newsletter Subscription

The Daily Beam

Product Watch

Bio & Life Sciences Product Watch

Laser Processing Product Watch

Get Published!

Photonics Hot List

Following the Photons: A Photonics Podcast

Social Media

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board